Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 473)
Posted On: 11/04/2024 10:47:37 PM
Post# of 154909
Posted By: ohm20
Re: Ramjet #147806
Quote:
For the Alzheimer's trial you mentioned that "conditional approval is possible on a phase 2 for that disease so a phase 3 would be unnecessary."

My question is this: Is that also true for the mssCRC trial? Is it possible that conditional approval on a phase 2 for that disease would make a phase 3 unnecessary?



Quote:
If I remember right, others also mentioned great ORR results can basis Cytodyn filing for early, Conditional Approval.
Quote:
In mssCRC with that size of patient population it's highly unlikely.


https://investorshangout.com/post/view?id=6727402



Besides the patient population size the difference between mssCRC and Alzheimer's is that there is no really viable approved drug for Alzheimer's.













(8)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site